上海洗霸(603200.SH):擬推278萬份的2021年股票期權激勵計劃
格隆匯10月13日丨上海洗霸(603200.SH)發佈2021年股票期權激勵計劃(草案),擬授予的股票期權數量為278萬份,約佔草案公吿時公司股本總額的2.219%。
該激勵計劃授予涉及的激勵對象共計221人,為: 1、公司及控股子公司董事、高級管理人員; 2、公司及控股公司核心管理人員、技術骨幹、項目骨幹和董事會認為的其他需要激勵的人員。
該激勵計劃授予的股票期權的行權價格為每份16.69元,即滿足行權條件後,激勵對象獲授的每一份股票期權擁有在行權期內以每份16.69元價格購買1股公司股票的權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.